Biodexa Pharmaceuticals (BDRX) is making progress in readying the launch of a phase 3 trial for eRapa, its proprietary encapsulated form of rapamycin being developed for the treatment of familial ...

The company recently received Fast Track designation from the FDA for eRapa, held a productive Type C meeting to finalize the Phase 3 protocol, and appointed clinical research organizations (CROs ...

Biodexa hopes to help with eRapa, a proprietary oral tablet formulation of rapamycin, also known as sirolimus, which slows down the mTOR (mammalian Target Of Rapamycin) protein. "Too much mTOR has ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Baznas telah menetapkan nominal uang yang setara zakat fitrah beras dengan jumlah tersebut berdasarkan harga beras di masing-masing daerah.

(NASDAQ:BDRX), a biopharmaceutical company focused on developing treatments for diseases with significant unmet medical needs, has announced progress in its preparations for a Phase 3 trial of eRapa, ...

tirto.id - Jelang Hari Raya Idul Fitri 2025, pemerintah Indonesia telah mengeluarkan Peraturan Menteri Keuangan (PMK) Nomor 23 Tahun 2025. Peraturan ini mengatur pemberian Tunjangan Hari Raya (THR) ...

A slew of corporate earnings are expected in the week ahead as tariff headlines have been whipsawing markets. Cash In on the Stock Market Sell-Off. 3 Elite Dividend Stocks Now Yielding Around 4% ...